Signalling molecule
NKG2D ligands
Molecules recognized by the activating immune receptor NKG2D
Hypotheses on this target 1
Lower level1
Synthesis suppression
Neutralisation
Supplementation
Accelerated excretion
Lower level1
Immune killing of normal regenerating cells may favor precancerous clone growth
Where this hypothesis actsNormal regenerating intestinal cells alongside Apc-altered cells
What is proposedEliminate NKG2D ligands selectively from normal cells
With whatControlled genetic model
HowGenetically restrict ligand changes to normal cells
Possible resultPossible reduction in later absolute growth of altered clones while preserving autophagic flux
2026-10-06